North American Pediatric Gastroenterology Fellowship Needs Assessment in Inflammatory Bowel Disease: Trainee and Program Director Perspectives

被引:6
|
作者
Dotson, Jennifer L. [1 ,2 ]
Falaiye, Tolulope [3 ]
Bricker, Josh B. [2 ]
Strople, Jennifer [4 ]
Rosh, Joel [5 ]
机构
[1] Nationwide Childrens Hosp, Div Pediat Gastroenterol Hepatol & Nutr, 700 Childrens Dr, Columbus, OH 43205 USA
[2] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA
[3] Penn State Hershey, Div Pediat Gastroenterol & Nutr, Hershey, PA USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Div Gastroenterol Hepatol & Nutr, Chicago, IL 60611 USA
[5] Goryeb Childrens Hosp, Div Gastroenterol & Nutr, Morristown, NJ USA
关键词
inflammatory bowel disease; pediatric gastroenterology; training; needs assessment;
D O I
10.1097/MIB.0000000000000801
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Pediatric inflammatory bowel disease (IBD) care is complex and rapidly evolving. The Crohn's and Colitis Foundation of America and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition cosponsored a needs assessment survey of pediatric gastroenterology trainees and program directors (PDs) to inform on educational programming.Methods:A Web-based, self-completed survey was provided to North American trainees and PDs during the 2013-2014 academic year. Standard descriptive statistics summarized demographics and responses.Results:One hundred sixty-six of 326 (51%) trainees (62% female) and 37 of 74 (50%) PDs responded. Median trainees per program = 5 and median total faculty = 10 (3 IBD experts); 15% of programs did not have a self-identified IBD expert faculty member. Sixty-nine percent of trainees were confident/somewhat confident in their IBD inpatient training, whereas 54% were confident/somewhat confident in their outpatient training. Trainees identified activities that would most improve their education, including didactics (55%), interaction with national experts (50%), trainee-centered IBD Web resources (42%), and increased patient exposure (42%). Trainees were most confident in managing inpatient active Crohn's disease/ulcerative colitis, phenotype classification, managing biological therapies, and using clinical disease activity indices. They were least confident in managing J-pouch complications, performing pouchoscopy, managing extraintestinal manifestations, and ostomy-related complications. Eighty-five percent would like an IBD-focused training elective. Most directors (86%) would allow trainees to do electives at other institutions.Conclusions:This IBD needs assessment survey of pediatric gastroenterology trainees and PDs demonstrated a strong resource commitment to IBD training and clinical care. Areas for educational enrichment emerged, including pouch and ostomy complications.
引用
收藏
页码:1616 / 1620
页数:5
相关论文
共 50 条
  • [41] The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From a Latin American Inflammatory Bowel Disease Program
    Simian, Daniela
    Flores, Lilian
    Quera, Rodrigo
    Ibanez, Patricio
    Figueroa, Carolina
    Lubascher, Jaime
    Pizarro, Gonzalo
    Kronberg, Udo
    GASTROENTEROLOGY NURSING, 2020, 43 (01) : E16 - E23
  • [42] End-of-Life Care Education in Pediatric Critical Care Medicine Fellowship Programs: Exploring Fellow and Program Director Perspectives
    Lyons, Kelly A.
    Middleton, Alyssa A.
    Farley, Alyssa A.
    Henderson, Natalie E.
    Peterson, Eleanor B.
    JOURNAL OF PALLIATIVE MEDICINE, 2023, 26 (09) : 1217 - 1224
  • [43] DEFINITION OF REMISSION IN INFLAMMATORY BOWEL DISEASE: ASSESSMENT OF PATIENT AND PHYSICIAN PERSPECTIVES
    Rubin, David
    Sninsky, Charles
    Siegmund, Britta
    Sans, Miquel
    Hart, Ailsa
    Bressler, Brian
    Bouhnik, Yoram
    Armuzzi, Alessandro
    Afzali, Anita
    GASTROENTEROLOGY, 2020, 158 (03) : S124 - S125
  • [44] DEFINITION OF REMISSION IN INFLAMMATORY BOWEL DISEASE: ASSESSMENT OF PATIENT AND PHYSICIAN PERSPECTIVES
    Rubin, David
    Sninsky, Charles
    Siegmund, Britta
    Sans, Miquel
    Hart, Ailsa
    Bressler, Brian
    Bouhnik, Yoram
    Armuzzi, Alessandro
    Afzali, Anita
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S77 - S77
  • [45] An Assessment of Mental Health Needs in Pediatric Patients With Inflammatory Bowel Disease (IBD) During the COVID-19 Pandemic
    Patel, Mayher
    Mathers, Emma
    Pescatello, Meredith
    Saubermann, Lawrence
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S23 - S24
  • [46] Evaluation of noncontrast MR enterography for pediatric inflammatory bowel disease assessment
    Lanier, Michael Hunter
    Shetty, Anup S.
    Salter, Amber
    Khanna, Geetika
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (02) : 341 - 348
  • [47] Assessment of Systemic Genetic Damage in Pediatric Inflammatory Bowel Disease.
    Dertinger, S. D.
    Baig, A.
    Avlasevich, S. L.
    Torous, D. K.
    Bemis, J. C.
    Saubermann, L. J.
    Lovell, D. P.
    MacGregor, J. T.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2020, 61 : 49 - 49
  • [48] Clostridium Difficile and Inflammatory Bowel Disease (Reprinted from Gastroenterology Clinics of North America, vol 38)
    Ananthakrishnan, Ashwin N.
    Issa, Mazen
    Binion, David G.
    MEDICAL CLINICS OF NORTH AMERICA, 2010, 94 (01) : 135 - +
  • [49] Treatment of Fistulizing Inflammatory Bowel Disease (Reprinted from Gastroenterology Clinics of North America, vol 38)
    Schwartz, David A.
    Maltz, Brad E.
    MEDICAL CLINICS OF NORTH AMERICA, 2010, 94 (01) : 19 - +
  • [50] Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
    Papamichael, Konstantinos
    Afif, Waqqas
    Drobne, David
    Dubinsky, Marla C.
    Ferrante, Marc
    Irving, Peter M.
    Kamperidis, Nikolaos
    Kobayashi, Taku
    Kotze, Paulo G.
    Lambert, Jo
    Noor, Nurulamin M.
    Roblin, Xavier
    Roda, Giulia
    Vande Casteele, Niels
    Yarur, Andres J.
    Arebi, Naila
    Danese, Silvio
    Paul, Stephane
    Sandborn, William J.
    Vermeire, Severine
    Cheifetz, Adam S.
    Peyrin-Biroulet, Laurent
    Monitoring, International Consortium for Therapeutic Drug
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 171 - 185